Savant Capital LLC reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 15.4% in the...
ETF
November 05, 2023, 02:45 am ET, BY Jake B.- Contributor| Editor: Thomas H. Kee Jr. (Follow on LinkedIn) Longer Term...
Introduced on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund intended to offer a wide...
McGuire Expense Group LLC reduced its stake in Worldwide X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Ranking) by 51.5%...
The iShares Biotechnology ETF (IBB) was released on 02/05/2001, and is a smart beta trade traded fund made to give...
Created to present broad publicity to the Health and fitness Care ETFs category of the market, the Invesco Dynamic Biotechnology...
